Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major.

Bhaumik S, Basu R, Sen S, Naskar K, Roy S.

Vaccine. 2009 Feb 25;27(9):1306-16. doi: 10.1016/j.vaccine.2008.12.053. Epub 2009 Jan 20.

PMID:
19162111
[PubMed - indexed for MEDLINE]
2.

Leishmaniasis: current status of vaccine development.

Sukumaran B, Madhubala R.

Curr Mol Med. 2004 Sep;4(6):667-79. Review.

PMID:
15357215
[PubMed - indexed for MEDLINE]
3.

Mechanisms of acquired immunity in leishmaniasis.

Howard JG, Liew FY.

Philos Trans R Soc Lond B Biol Sci. 1984 Nov 13;307(1131):87-98. Review.

PMID:
6151691
[PubMed - indexed for MEDLINE]
4.

Immunity and immunosuppression in experimental visceral leishmaniasis.

Goto H, Lindoso JA.

Braz J Med Biol Res. 2004 Apr;37(4):615-23. Epub 2004 Mar 23. Review.

PMID:
15064826
[PubMed - indexed for MEDLINE]
Free Article
5.

Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis.

Ravindran R, Ali N.

Curr Mol Med. 2004 Sep;4(6):697-709. Review.

PMID:
15357218
[PubMed - indexed for MEDLINE]
6.

Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy.

Travassos LR, Rodrigues EG, Iwai LK, Taborda CP.

Mycopathologia. 2008 Apr-May;165(4-5):341-52. Review.

PMID:
18777638
[PubMed - indexed for MEDLINE]
7.

Interleukin-10 and the pathogenesis of human visceral leishmaniasis.

Nylén S, Sacks D.

Trends Immunol. 2007 Sep;28(9):378-84. Epub 2007 Aug 6. Review.

PMID:
17689290
[PubMed - indexed for MEDLINE]
8.

Applications of molecular methods for Leishmania control.

Singh S, Dey A, Sivakumar R.

Expert Rev Mol Diagn. 2005 Mar;5(2):251-65. Review.

PMID:
15833054
[PubMed - indexed for MEDLINE]
9.

Balancing immunity and pathology in visceral leishmaniasis.

Stanley AC, Engwerda CR.

Immunol Cell Biol. 2007 Feb-Mar;85(2):138-47. Epub 2006 Dec 5. Review.

PMID:
17146466
[PubMed - indexed for MEDLINE]
10.

Immunopathology of leishmaniasis: an update.

Mansueto P, Vitale G, Di Lorenzo G, Rini GB, Mansueto S, Cillari E.

Int J Immunopathol Pharmacol. 2007 Jul-Sep;20(3):435-45. Review.

PMID:
17880757
[PubMed - indexed for MEDLINE]
11.

Secreted virulence factors and immune evasion in visceral leishmaniasis.

Lambertz U, Silverman JM, Nandan D, McMaster WR, Clos J, Foster LJ, Reiner NE.

J Leukoc Biol. 2012 Jun;91(6):887-99. doi: 10.1189/jlb.0611326. Epub 2012 Mar 21. Review.

PMID:
22442494
[PubMed - indexed for MEDLINE]
Free Article
12.

A detrimental role for IgG and FcgammaR in Leishmania mexicana infection.

Buxbaum LU.

Immunol Res. 2008;42(1-3):197-209. doi: 10.1007/s12026-008-8074-5. Review.

PMID:
19002608
[PubMed - indexed for MEDLINE]
13.

Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment.

Roberts MT.

Br Med Bull. 2006 Jul 17;75-76:115-30. Print 2005. Review.

PMID:
16847165
[PubMed - indexed for MEDLINE]
14.

Discovery of novel vaccine candidates and drug targets against visceral leishmaniasis using proteomics and transcriptomics.

Kumari S, Kumar A, Samant M, Singh N, Dube A.

Curr Drug Targets. 2008 Nov;9(11):938-47. Review.

PMID:
18991606
[PubMed - indexed for MEDLINE]
15.

Cutaneous leishmaniasis: progress towards a vaccine.

Launois P, Tacchini-Cottier F, Kieny MP.

Expert Rev Vaccines. 2008 Oct;7(8):1277-87. doi: 10.1586/14760584.7.8.1277. Review.

PMID:
18844599
[PubMed - indexed for MEDLINE]
16.

Cytokine profiles in canine visceral leishmaniasis.

Carrillo E, Moreno J.

Vet Immunol Immunopathol. 2009 Mar 15;128(1-3):67-70. doi: 10.1016/j.vetimm.2008.10.310. Epub 2008 Oct 17. Review.

PMID:
19054573
[PubMed - indexed for MEDLINE]
17.

DNA topoisomerases of Leishmania: the potential targets for anti-leishmanial therapy.

Das BB, Ganguly A, Majumder HK.

Adv Exp Med Biol. 2008;625:103-15. doi: 10.1007/978-0-387-77570-8_9. Review.

PMID:
18365662
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk